Special Considerations for Testing for Extractables and Leachables
May 30, 2013
By BioPharm International Editors
Rita Peters, Editorial Director for Pharmaceutical Technology and BioPharm Inernational talks with Ferdinand Dabu, director of marketing at SGS live at Interphex 2013 about extractables and leachables. In this interview they discuss special considerations for testing for extractables and leachables for both small molecule and biological drug development.
Contract manufacturers are essential players that allow biopharmaceutical companies the flexibility to address fluctuating product demand and the ability to outsource projects that are not strategically critical..